Beranda › Kanker Saluran Empedu › Pennsylvania › Pittsburgh
Uji klinis Kanker Saluran Empedu di Pittsburgh, PA
7 studi untuk Kanker Saluran Empedu mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Menerima pesertaFase 3
- Research Site, Pittsburgh
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Menerima pesertaFase 1/2
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Menerima pesertaFase 1
- UPMC Hillman Cancer Center, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Menerima pesertaFase 1
- UPMC, Pittsburgh
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Menerima pesertaFase 3
- Research Site, Pittsburgh
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Menerima pesertaFase 2
- UPMC Hillman Cancer Center, Pittsburgh
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Menerima peserta
- AHN West Penn Hospital, Pittsburgh
Uji klinis Kanker Saluran Empedu di kota lain
- Houston, TX18 studi
- Los Angeles, CA11 studi
- Boston, MA11 studi
- New York City, NY10 studi
- Nashville, TN9 studi
- Baltimore, MD8 studi
- San Antonio, TX8 studi
- Washington, DC7 studi
- Arlington, VA7 studi
- Madison, WI6 studi
- Columbus, OH6 studi
- Cleveland, OH6 studi
Studi lain di Pittsburgh
- Kanker Paru Non-Sel Kecil48 studi
- Kanker (semua jenis)41 studi
- Kanker Payudara39 studi
- Kanker Kolorektal32 studi
- Kanker Metastatik31 studi
- Melanoma31 studi
- Kanker Ovarium30 studi
- Kanker Endometrium23 studi
- Kanker Prostat23 studi
- Kanker Paru23 studi
- Karsinoma Sel Skuamosa Kepala dan Leher22 studi
- Stroke22 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.